These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways. Xu EY; Schaefer WH; Xu Q Curr Opin Drug Discov Devel; 2009 Jan; 12(1):40-52. PubMed ID: 19152212 [TBL] [Abstract][Full Text] [Related]
3. Application of genomics, proteomics and metabolomics in drug discovery, development and clinic. Russell C; Rahman A; Mohammed AR Ther Deliv; 2013 Mar; 4(3):395-413. PubMed ID: 23442083 [TBL] [Abstract][Full Text] [Related]
4. Metabolomic investigations of human infections. Pacchiarotta T; Deelder AM; Mayboroda OA Bioanalysis; 2012 May; 4(8):919-25. PubMed ID: 22533566 [TBL] [Abstract][Full Text] [Related]
5. Lipidomics in situ: insights into plant lipid metabolism from high resolution spatial maps of metabolites. Horn PJ; Chapman KD Prog Lipid Res; 2014 Apr; 54():32-52. PubMed ID: 24480404 [TBL] [Abstract][Full Text] [Related]
6. UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics. Zhao YY; Lin RC Chem Biol Interact; 2014 May; 215():7-16. PubMed ID: 24631021 [TBL] [Abstract][Full Text] [Related]
7. Lipidomics applications for disease biomarker discovery in mammal models. Zhao YY; Cheng XL; Lin RC; Wei F Biomark Med; 2015; 9(2):153-68. PubMed ID: 25689902 [TBL] [Abstract][Full Text] [Related]
8. Human metabolomics: strategies to understand biology. Ramautar R; Berger R; van der Greef J; Hankemeier T Curr Opin Chem Biol; 2013 Oct; 17(5):841-6. PubMed ID: 23849548 [TBL] [Abstract][Full Text] [Related]
9. Platforms for biomarker analysis using high-throughput approaches in genomics, transcriptomics, proteomics, metabolomics, and bioinformatics. Merrick BA; London RE; Bushel PR; Grissom SF; Paules RS IARC Sci Publ; 2011; (163):121-42. PubMed ID: 22997859 [TBL] [Abstract][Full Text] [Related]
10. Metabolome 2.0: quantitative genetics and network biology of metabolic phenotypes. Dumas ME Mol Biosyst; 2012 Oct; 8(10):2494-502. PubMed ID: 22868675 [TBL] [Abstract][Full Text] [Related]
12. Metabolomics in infectious diseases and drug discovery. Tounta V; Liu Y; Cheyne A; Larrouy-Maumus G Mol Omics; 2021 Jun; 17(3):376-393. PubMed ID: 34125125 [TBL] [Abstract][Full Text] [Related]
13. Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes. Abu Bakar MH; Sarmidi MR; Cheng KK; Ali Khan A; Suan CL; Zaman Huri H; Yaakob H Mol Biosyst; 2015 Jul; 11(7):1742-74. PubMed ID: 25919044 [TBL] [Abstract][Full Text] [Related]
14. [Recent advances in metabonomics]. Xu GW; Lu X; Yang SL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):701-11. PubMed ID: 18595244 [TBL] [Abstract][Full Text] [Related]
15. Metabolomics reviewed: a new "omics" platform technology for systems biology and implications for natural products research. Rochfort S J Nat Prod; 2005 Dec; 68(12):1813-20. PubMed ID: 16378385 [TBL] [Abstract][Full Text] [Related]
16. Integrated omics approaches in plant systems biology. Fukushima A; Kusano M; Redestig H; Arita M; Saito K Curr Opin Chem Biol; 2009 Dec; 13(5-6):532-8. PubMed ID: 19837627 [TBL] [Abstract][Full Text] [Related]
18. Metabolomics for Biomarker Discovery: Moving to the Clinic. Zhang A; Sun H; Yan G; Wang P; Wang X Biomed Res Int; 2015; 2015():354671. PubMed ID: 26090402 [TBL] [Abstract][Full Text] [Related]